Quantification of functional abilities in Rett syndrome: a comparison between stages III and IV

Imagem de Miniatura
Arquivos
art_MONTEIRO_Quantification_of_functional_abilities_in_Rett_syndrome_a_2014.PDF (376.76 KB)
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Autores
MONTEIRO, Carlos B. M.
SAVELSBERGH, Geert J. P.
SMORENBURG, Ana R. P.
GRACIANI, Zodja
TORRIANI-PASIN, Camila
ABREU, Luiz Carlos de
VALENTI, Vitor E.
Citação
NEUROPSYCHIATRIC DISEASE AND TREATMENT, v.10, p.1213-1222, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We aimed to evaluate the functional abilities of persons with Rett syndrome (RTT) in stages III and IV. The group consisted of 60 females who had been diagnosed with RTT: 38 in stage III, mean age (years) of 9.14, with a standard deviation of 5.84 (minimum 2.2/maximum 26.4); and 22 in stage IV, mean age of 12.45, with a standard deviation of 6.17 (minimum 5.3/maximum 26.9). The evaluation was made using the Pediatric Evaluation of Disability Inventory, which has 197 items in the areas of self-care, mobility, and social function. The results showed that in the area of self-care, stage III and stage IV RTT persons had a level of 24.12 and 18.36 (P=0.002), respectively. In the area of mobility, stage III had 37.22 and stage IV had 14.64 (P<0.001), while in the area of social function, stage III had 17.72 and stage IV had 12.14 (P=0.016). In conclusion, although persons with stage III RTT have better functional abilities when compared with stage IV, the areas of mobility, self-care, and social function are quite affected, which shows a great functional dependency and need for help in basic activities of daily life.
Palavras-chave
Rett syndrome, disability evaluation, self-care, mobility limitation
URI
https://observatorio.fm.usp.br/handle/OPI/7553
Referências
  1. Amir RE, 1999, NAT GENET, V23, P185
  2. ARMSTRONG DD, 1992, BRAIN DEV-JPN, V14, pS89
  3. Baptista PM, 2006, J INTELL DISABIL RES, V50, P662, DOI 10.1111/j.1365-2788.2006.00818.x
  4. Bianciardi G, 2013, CLIN HEMORHEOL MICRO, V54, P109, DOI 10.3233/CH-131707
  5. Brandao MD, 2010, CLIN REHABIL, V24, P639, DOI 10.1177/0269215510367974
  6. Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-x
  7. Cohen J, 1988, STAT POWER ANAL BEHA
  8. Colvin L, 2004, J MED GENET, V41, P25, DOI 10.1136/jmg.2003.011130
  9. De Felice C, 2012, ANN NY ACAD SCI, V1259, P121, DOI 10.1111/j.1749-6632.2012.06611.x
  10. Djukic A, 2012, PEDIATR NEUROL, V46, P240, DOI 10.1016/j.pediatrneurol.2012.01.011
  11. Dolce A, 2013, PEDIATR NEUROL, V48, P337, DOI 10.1016/j.pediatrneurol.2012.11.001
  12. Downs J, 2010, DEV MED CHILD NEUROL, V52, P817, DOI 10.1111/j.1469-8749.2010.03636.x
  13. Dunn HG, 2001, BRAIN DEV-JPN, V23, pS38, DOI 10.1016/S0387-7604(01)00335-7
  14. Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.88
  15. Fabio RA, 2009, RES DEV DISABIL, V30, P136, DOI 10.1016/j.ridd.2008.01.003
  16. Fehr S, 2010, AM J MED GENET A, V152A, P2535, DOI 10.1002/ajmg.a.33640
  17. Foley KR, 2011, J CHILD NEUROL, V26, P1237, DOI 10.1177/0883073811402688
  18. Gonnelli S, 2008, BONE, V42, P737, DOI 10.1016/j.bone.2007.12.003
  19. Gratchev VV, 2001, BRAIN DEV-JPN, V23, pS108, DOI 10.1016/S0387-7604(01)00359-X
  20. Grillo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056599
  21. Guarany Nicole Ruas, 2012, J Pediatr Rehabil Med, V5, P37, DOI 10.3233/PRM-2012-0194
  22. Hagberg B, 1986, Am J Med Genet Suppl, V1, P47
  23. Hagberg Bengt, 2002, Eur J Paediatr Neurol, V6, P293, DOI 10.1053/ejpn.2002.0612
  24. HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372
  25. HAGBERG BA, 1989, PEDIATR NEUROL, V5, P75, DOI 10.1016/0887-8994(89)90031-3
  26. Halbach NSJ, 2013, CLIN GENET, V84, P223, DOI 10.1111/cge.12063
  27. Haley S, 1992, PEDIAT EVALUATION DI
  28. Hardwick SA, 2007, EUR J HUM GENET, V15, P1218, DOI 10.1038/sj.ejhg.5201911
  29. Hofstaetter JG, 2010, BONE, V47, P701, DOI 10.1016/j.bone.2010.06.005
  30. Jian L, 2006, J PEDIATR-US, V149, P542, DOI 10.1016/j.jpeds.2006.06.015
  31. KERR AM, 1995, NEUROPEDIATRICS, V26, P67, DOI 10.1055/s-2007-979725
  32. Kirby RS, 2010, J PEDIATR-US, V156, P135, DOI 10.1016/j.jpeds.2009.07.015
  33. Lane JB, 2011, NEUROLOGY, V77, P1812, DOI 10.1212/WNL.0b013e3182377dd2
  34. Larsson G, 2001, BRAIN DEV, V23, P77
  35. Larsson G, 2013, RES DEV DISABIL, V34, P1897, DOI 10.1016/j.ridd.2013.02.027
  36. Larsson G, 2005, BRAIN DEV-JPN, V27, pS14, DOI 10.1016/j.braindev.2005.03.015
  37. Lim F, 2013, DISABIL REHABIL, V35, P343, DOI 10.3109/09638288.2012.715720
  38. Lin KC, 2012, RES DEV DISABIL, V33, P570, DOI 10.1016/j.ridd.2011.10.003
  39. Lotan M, 2004, J INTELL DISABIL RES, V48, P730, DOI 10.1111/j.1365-2788.2003.00589.x
  40. Malheiros SR, 2013, INT ARCH MED, V6, P1
  41. Mancini MC., 2005, INVENTARIO AVALIACAO
  42. Marschik PB, 2013, RES DEV DISABIL, V34, P1236, DOI 10.1016/j.ridd.2013.01.014
  43. Marschik PB, 2012, RES DEV DISABIL, V33, P1749, DOI 10.1016/j.ridd.2012.04.012
  44. Matson JL, 2008, EUR PSYCHIAT, V23, P460, DOI 10.1016/j.eurpsy.2007.11.008
  45. Monteggia LM, 2009, BIOL PSYCHIAT, V65, P204, DOI 10.1016/j.biopsych.2008.10.036
  46. Monteiro CBD, 2012, HEALTHMED, V6, P2464
  47. Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009
  48. Moser SJ, 2007, PEDIATR NEUROL, V36, P95, DOI 10.1016/j.pediatrneurol.2006.10.003
  49. Motil KJ, 2011, J PEDIATR GASTR NUTR, V53, P569, DOI 10.1097/MPG.0b013e3182267a66
  50. Motil KJ, 2012, J PEDIATR GASTR NUTR, V55, P292, DOI 10.1097/MPG.0b013e31824b6159
  51. Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236
  52. Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124
  53. Nissenkorn A, 2010, EPILEPSIA, V51, P1252, DOI 10.1111/j.1528-1167.2010.02597.x
  54. NOMURA Y, 1992, BRAIN DEV-JPN, V14, pS21
  55. O'Connor RD, 2009, BONE, V45, P346, DOI 10.1016/j.bone.2009.04.251
  56. Ohrvall AM, 2010, DEV MED CHILD NEUROL, V52, P1048, DOI 10.1111/j.1469-8749.2010.03764.x
  57. Pini G, 2012, NEUROPEDIATRICS, V43, P37, DOI 10.1055/s-0032-1308856
  58. Pintaudi M, 2010, EPILEPSY BEHAV, V19, P296, DOI 10.1016/j.yebeh.2010.06.051
  59. Prince E, 2011, CURR OPIN NEUROL, V24, P154, DOI 10.1097/WCO.0b013e3283444c70
  60. RETT A, 1992, BRAIN DEV-JPN, V14, pS141
  61. Rett A, 1966, Wien Med Wochenschr, V116, P723
  62. Segawa M, 2005, CURR OPIN NEUROL, V18, P97, DOI 10.1097/01.wco.0000162848.99154.9a
  63. Segawa M, 2001, BRAIN DEV-JPN, V23, pS218, DOI 10.1016/S0387-7604(01)00372-2
  64. Segawa M, 2005, BRAIN DEV-JPN, V27, pS54, DOI 10.1016/j.braindev.2004.11.010
  65. Signorini C, 2013, OXIDATIVE MED CELLUL, V2013
  66. Tellegen CL, 2013, RES DEV DISABIL, V34, P1556, DOI 10.1016/j.ridd.2013.01.022
  67. Temudo T, 2011, BRAIN DEV-JPN, V33, P69, DOI 10.1016/j.braindev.2010.01.004
  68. Zoghbi HY, 2009, NAT NEUROSCI, V12, P239, DOI 10.1038/nn0309-239
  69. Zysman L, 2006, THESCIENTIFICWORLDJO, V6, P1619, DOI 10.1100/tsw.2006.266

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15